Levels of oxidative stress and apoptosis-related biomarkers in endometriosis
Öz
Purpose: In this study, the apoptosis marker M30, the oxidative stress markers malondialdehyde, (MDA) and asymmetric dimethyl arginine (ADMA) have been studied in the context of endometriosis.
Materials and Methods: This prospective case-control study comprises 31 patients diagnosed with endometriosis and 31 controls. ADMA and M30 levels in blood serum were measured by the enzyme-linked immunosorbent assay (ELISA) method, and MDA levels were measured by the spectrophotometric method. In addition, some biochemical parameters and cancer antigen-125 (CA-125) levels were also measured.
Results: M30 levels were statistically lower in endometriosis patients (271.5 IU/L) than in controls (371.3 IU/L). ADMA levels were higher in endometriosis patients (19.3 ng/L) compared to controls (12.7 ng/L). CA-125 levels were statistically higher in the endometriosis patients (65.1 U/mL) compared to the controls (19.0 U/mL). There was no significant difference between the two groups in MDA levels. The results regarding dyspareunia, pelvic pain, AST, and ALP were statistically significant.
Conclusion: In our study, decreased M30 levels in the patient group were associated with reduced apoptosis in endometriosis. ADMA levels, elevated with the increase of oxidative stress, were higher in the patients. MDA levels, an indicator of increased oxidative stress, were also higher in the patient group. This study constitutes the first data regarding endometriosis patients' ADMA, M30, and MDA levels.
Anahtar Kelimeler
Apoptosis, ADMA, Endometriosis, MDA, M30
Destekleyen Kurum
Sivas Cumhuriyet Üniversitesi Bilimsel Araştırma Projeleri
Proje Numarası
T-606
Teşekkür
The researchers thank Ziynet Çınar, Ph.D, for statistical analysis support. This study was supported as a Master Thesis by the Sivas Cumhuriyet University Scientific Research Projects (CÜBAP) project numbered T-606.
Kaynakça
- Kao LGL, Giudice L. Endometriosis. Lancet. 2004;364:1789-99.
- Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, Hearns-Stokes R et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril. 2003;79:1078-85.
- Brosens I, Puttemans P, Campo R, Gordts S, Brosens J. Non-invasive methods of diagnosis of endometriosis. Curr Opin Obstet Gynecol. 2003;15:519-22.
- Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14:422-69.
- Chantalat E, Valera MC, Vaysse C, Noirrit E, Rusidze M, Weyl A et al. Estrogen receptors and endometriosis. Int J Mol Sci. 2020;21:2815.
- Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017;96:623-32.
- Yang WC, Chen HW, Au HK, Chang CW, Huang CT, Yen YH et al. Serum and endometrial markers. Best Pract Res Clin Obstet Gynaecol. 2004;18:305-18.
- Gonçalves G, Camargo-Kosugi C, Bonetti T, Invitti A, Girão M, Silva I et al. p27 kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis. Apoptosis. 2015;20:327-35.
- Gaben AM, Saucier Cc, Bedin M, Redeuilh Gr, Mester J. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase. Mol Endocrinol. 2004;18:2700-13.
- Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors. Hum Reprod Update. 2019;25:473-85.
